TARA EPS Estimates
Protara Therapeutics, Inc.
$2.48
-$0.14(-5.34%)
35
Overall
60
Value
18
Tech
28
Quality
Market Cap
$146.56M
Volume
705.52K
52W Range
$2.51 - $7.82
Target Price
$26.57
TARA EPS estimates: the consensus estimate for Protara Therapeutics, Inc.'s current fiscal year is -$1.40 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TARA EPS Estimates
- EPS estimate, current quarter
- $-0.37
- EPS estimate, next quarter
- $-0.38
- EPS estimate, current year
- $-1.40
- EPS estimate, next year
- $-1.69
- EPS growth, 3-year
- +38.85%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.34 |
| 2024 | $-2.17 |
| 2023 | $-3.57 |
| 2022 | $-5.86 |
| 2021 | $-4.21 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARA | $2.48 | -5.3% | 705.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protara Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW